English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2541316      線上人數 : 188
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/60480


    題名: 雜環二萜之合成與活性評估
    Synthesis and biological evaluation of heterocyclic diterpenoids
    作者: 黃柏華
    HUANG, BO-HUA
    貢獻者: 藥學系碩士班
    林淑娟
    關鍵詞: 雜環二萜;甜菊苷
    stevioside;steviol;isosteviol
    日期: 2021-01-20
    上傳時間: 2021-03-10 11:00:51 (UTC+8)
    摘要: 甜菊苷(stevioside)為甜菊(Stevia rebaudiana (Bertoni) Bertoni)的四環二萜類配糖體成分,文獻指出stevioside具有降血糖、降血壓、抗發炎及抗癌等功效。stevioside利用酸水解可得到甜菊醇(steviol)及異甜菊醇(isosteviol),而isosteviol經由Beckmann rearrangement可得到具有內醯胺(lactam)結構的4α-isocyanato-13α-amino-13,16-seco-ent-19-norbeyerane衍生物,三個四環二萜結構上的不同主要於D環。過去本實驗室曾以isosteviol及steviol為起始物,針對C-4的羧基(carboxylic group)進行修飾,個別得到異氰酸酯(isocyanate)的基團,經與一級胺化合物反應,得到具ureido結構的衍生物,經抗B型肝炎病毒的活性試驗顯示,兩系列有效化合物的作用機轉不同。為了尋找具新標的及作用機轉的抗B型肝炎病毒的化合物,以及探討不同D環的四環二萜結構與活性的關係,因此本研究利用isosteviol、steviol及isosteviol lactam三種結構進行修飾,得到其isocyanate的衍生物做為中間產物,接著與各種二級胺類化合物反應,得到醯胺(amide)衍生物,這些化合物皆經由核磁共振及高解析質譜鑑定其結構。初步抗B型肝炎病毒的活性試驗發現,這些化合物對抑制B型肝炎病毒複製的能力不甚理想。此外,這些化合物經由MTT assay進行初步MDA-MB-231及MCF-7乳癌細胞株的毒殺(cytotoxicity)試驗結果發現,化合物8、15和20於10 μM時,對於MCF-7細胞株反應與對照組有明顯差異,進一步試驗目前進行中。
    Stevioside, a tetracyclic diterpenoid glycoside, which can be isolated in the leaves of Stevia rebaudiana (Bertoni) Bertoni. Stevioside possesses many biological activities, including anti-hyperglycemic, anti-hypertensive, anti-inflammatory and anti-tumor. Acid hydrolysis of stevioside can obtain ent-kaurene of steviol and ent-beyerane of isosteviol. Additionally, isosteviol can undergo the Beckmann rearrangement to produce the lactam derivative, 4α-isocyanato-13α-amino-13,16-seco-ent-19-norbeyerane. In our lab, we used isosteviol and steviol as starting materials to synthesize several C-4 ureido derivatives by transforming C-4 carboxylic group of isosteviol and steviol to isocyanate derivatives and then reacting with different primary amines to give C-4 ureido derivatives. The active compounds of two series of synthesized derivatives showed different action mechanisms. In order to investigative the relationship between anti-HBV activity and D ring of different tetracyclic diterpenoids, several derivatives are prepared by reacting isocyanate derivatives of isosteviol, steviol and isosteviol lactam with secondary amines to form amide derivatives. Structures of derivatives are determined by NMR and HRMS. The preliminary testing for anti-HBV activity of these derivatives are not active. Additionally, these synthesized compounds were also tested for cytotoxicity on MDA-MB-231 and MCF-7 breast cancer cell lines by MTT assay. The results show that compounds 8, 15 and 20 at 10 μM display significant differences in MCF-7 cell line by comparison with the control group. Further testing is still in progress.
    描述: 碩士
    指導教授:林淑娟
    委員:許秀蘊
    委員:王莉萱
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML124檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋